BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 33744177)

  • 1. The "rail sign": an ultrasound finding in placenta accreta spectrum indicating deep villous invasion and adverse outcomes.
    Shih JC; Kang J; Tsai SJ; Lee JK; Liu KL; Huang KY
    Am J Obstet Gynecol; 2021 Sep; 225(3):292.e1-292.e17. PubMed ID: 33744177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accreta placentation: a systematic review of prenatal ultrasound imaging and grading of villous invasiveness.
    Jauniaux E; Collins SL; Jurkovic D; Burton GJ
    Am J Obstet Gynecol; 2016 Dec; 215(6):712-721. PubMed ID: 27473003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of transvaginal ultrasound in the third-trimester evaluation of patients at high risk of placenta accreta spectrum at birth.
    Jauniaux E; Hussein AM; Thabet MM; Elbarmelgy RM; Elbarmelgy RA; Jurkovic D
    Am J Obstet Gynecol; 2023 Oct; 229(4):445.e1-445.e11. PubMed ID: 37187303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of ultrasound in prediction of intra-operative blood loss in cases of placenta accreta spectrum disorders.
    Hussein AM; Momtaz M; Elsheikhah A; Abdelbar A; Kamel A
    Arch Gynecol Obstet; 2020 Nov; 302(5):1143-1150. PubMed ID: 32740869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective evaluation of impact of post-Cesarean section uterine scarring in perinatal diagnosis of placenta accreta spectrum disorder.
    Hussein AM; Elbarmelgy RA; Elbarmelgy RM; Thabet MM; Jauniaux E
    Ultrasound Obstet Gynecol; 2022 Apr; 59(4):474-482. PubMed ID: 34225385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends, characteristics, and outcomes of placenta accreta spectrum: a national study in the United States.
    Matsuzaki S; Mandelbaum RS; Sangara RN; McCarthy LE; Vestal NL; Klar M; Matsushima K; Amaya R; Ouzounian JG; Matsuo K
    Am J Obstet Gynecol; 2021 Nov; 225(5):534.e1-534.e38. PubMed ID: 33894149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Placenta accreta spectrum: pathophysiology and evidence-based anatomy for prenatal ultrasound imaging.
    Jauniaux E; Collins S; Burton GJ
    Am J Obstet Gynecol; 2018 Jan; 218(1):75-87. PubMed ID: 28599899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implementation and outcomes of a uterine artery embolization and tranexamic acid protocol for placenta accreta spectrum.
    Munoz JL; Blankenship LM; Ramsey PS; McCann GA
    Am J Obstet Gynecol; 2023 Jul; 229(1):61.e1-61.e7. PubMed ID: 36965865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Placenta Accreta Spectrum Treatment With Intraoperative Multivessel Embolization: the PASTIME protocol.
    Melber DJ; Berman ZT; Jacobs MB; Picel AC; Conturie CL; Zhang-Rutledge K; Binder PS; Eskander RN; Roberts AC; McHale MT; Ramos GA; Ballas J; Kelly TF
    Am J Obstet Gynecol; 2021 Oct; 225(4):442.e1-442.e10. PubMed ID: 34245679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transabdominal and transvaginal ultrasound findings help to guide the clinical management of placenta accreta spectrum cases.
    Aryananda RA; Duvekot JJ; Van Beekhuizen HJ; Cininta NI; Ariani G; Dachlan EG
    Acta Obstet Gynecol Scand; 2024 Jan; 103(1):93-102. PubMed ID: 37968904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intracervical lakes as sonographic marker of placenta accreta spectrum disorder in patients with placenta previa or low-lying placenta.
    di Pasquo E; Ghi T; Calì G; D'Antonio F; Fratelli N; Forlani F; Prefumo F; Kaihura CT; Volpe N; Dall'Asta A; Frusca T
    Ultrasound Obstet Gynecol; 2020 Apr; 55(4):460-466. PubMed ID: 31503353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new methodologic approach for clinico-pathologic correlations in invasive placenta previa accreta.
    Jauniaux E; Hussein AM; Zosmer N; Elbarmelgy RM; Elbarmelgy RA; Shaikh H; Burton GJ
    Am J Obstet Gynecol; 2020 Apr; 222(4):379.e1-379.e11. PubMed ID: 31730756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes following a clinical algorithm allowing for delayed hysterectomy in the management of severe placenta accreta spectrum.
    Zuckerwise LC; Craig AM; Newton JM; Zhao S; Bennett KA; Crispens MA
    Am J Obstet Gynecol; 2020 Feb; 222(2):179.e1-179.e9. PubMed ID: 31469990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Three-dimensional volume rendering ultrasound for assessing placenta accreta spectrum severity and discriminating it from simple scar dehiscence.
    Adu-Bredu TK; Ridwan R; Aditiawarman A; Ariani G; Collins SL; Aryananda RA
    Am J Obstet Gynecol MFM; 2024 Apr; 6(4):101321. PubMed ID: 38460827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Placenta accreta spectrum: Risk factors, diagnosis and management with special reference to the Triple P procedure.
    Piñas Carrillo A; Chandraharan E
    Womens Health (Lond); 2019; 15():1745506519878081. PubMed ID: 31578123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of placenta accreta by ultrasonography and color Doppler imaging.
    Woodring TC; Klauser CK; Bofill JA; Martin RW; Morrison JC
    J Matern Fetal Neonatal Med; 2011 Jan; 24(1):118-21. PubMed ID: 20446895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes associated with peripartum hysterectomy in the setting of placenta accreta spectrum disorder.
    Overton E; Wen T; Friedman AM; Azad H; Nhan-Chang CL; Booker WA; Khoury-Collado F; Mourad M
    Am J Obstet Gynecol MFM; 2023 Dec; 5(12):101174. PubMed ID: 37802412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prenatal diagnosis of placenta previa accreta by transabdominal color Doppler ultrasound.
    Chou MM; Ho ES; Lee YH
    Ultrasound Obstet Gynecol; 2000 Jan; 15(1):28-35. PubMed ID: 10776009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of maternal outcomes and clinical characteristics of prenatally vs nonprenatally diagnosed placenta accreta spectrum: a systematic review and meta-analysis.
    Sugai S; Yamawaki K; Sekizuka T; Haino K; Yoshihara K; Nishijima K
    Am J Obstet Gynecol MFM; 2023 Dec; 5(12):101197. PubMed ID: 37865220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Failure of placental detachment in accreta placentation is associated with excessive fibrinoid deposition at the utero-placental interface.
    Jauniaux E; Hussein AM; Elbarmelgy RM; Elbarmelgy RA; Burton GJ
    Am J Obstet Gynecol; 2022 Feb; 226(2):243.e1-243.e10. PubMed ID: 34461077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.